Issue |
Title |
File |
No 11 (2015) |
PATHOGENETIC RATIONALE FOR THE THERAPY OF CHRONIC ENDOMETRITIS |
|
GOMBOLEVSKAYA N.A., MARCHENKO L.A.
|
No 9 (2024) |
Pathogenetic therapy of benign breast dysplasia |
|
Meskikh E.V., Ashrafyan L.A.
|
No 8 (2011) |
PATHOGENETIC TREATMENT FOR BACTERIAL DYSBIOSES |
|
TKACHENKO L.V., BOGATYREVA L.N.
|
No 9 (2020) |
Pathogenetically based therapy for cyclic mastalgia |
|
Tazina T.V.
|
No 8 (2016) |
Pathogenic approach to treating patients with primary dysmenorrhea |
|
Buralkina N.A., Borisenko M.Y., Latypova N.H.
|
No 11 (2022) |
Pathogenic variants in the BRCA 1 and BRCA2 genes: what is important for a practicing gynecologist to know |
|
Yureneva S.V., Averyanova M.V., Ashrafyan L.A., Yakushevskaya O.V., Buyanovskaya O.A.
|
No 5 (2018) |
Pathological placentation and prediction of preeclampsia and intrauterine growth restriction in the first trimester |
|
Kholin A.M., Khodzhaeva Z.S., Gus A.I.
|
No 3 (2014) |
PATHOMORPHOLOGICAL CHARACTERISTICS OF BRAIN LESION IN SEVERE PREECLAMPSIA AND ECLAMPSIA |
|
SIDOROVA I.S., MILOVANOV A.P., NIKITINA N.A., RZAEVA A.A.
|
No 8 (2021) |
Pathomorphological features of placenta in patients with different clinical phenotypes of spontaneous preterm births |
|
Remneva O.V., Kolyado O.V., Pesotskaya A.V., Starodubtsev E.G., Gumenyuk I.S.
|
No 1 (2010) |
Pathophysiological bases of ultrasound monitoring of the fetus in its growth retardation syndrome |
|
Kovalev V.V., Tsyvyan P.B.
|
No 5 (2011) |
PATHOPHYSIOLOGICAL MECHANISMS OF DEVELOPMENT OF NEUROLOGICAL COMPLICATIONS OF ECLAMPSIA: SYSTEMS REVIEW |
|
SHIFMAN E.M., FLOKA S.E., TIKHOVA G.P., KHRAMCHENKO N.V.
|
No 7-2 (2011) |
PATHOPHYSIOLOGICAL MECHANISMS OF EXTENSION OF THE COLLAR SPACE |
|
KOVALEV V.V., TSYVYAN P.B., KOVALEVA N.V.
|
No 1 (2018) |
PATHOPHYSIOLOGICAL MECHANISMS OF OBSTETRIC ANTIPHOSPHOLIPID SYNDROME |
|
MENZHINSKAYA I.V., VANKO L.V.
|
No 7 (2013) |
PATIENT SATISFACTION AS ONE OF THE CRITERIA FOR OBSTETRIC AND GYNECOLOGIC CARE QUALITY (According to the results of analyzing written complaints from the population of Nizhny Novgorod) |
|
FILIPPOV Y.N., ABAYEVA O.P., FILIPPOV A.Y., SHCHELTSINA N.Y.
|
No 10 (2017) |
Patient-centered care: The vector of development of obstetric hospital |
|
Shuvalova M.P., Pismenskaya T.V., Kan N.E., Tyutyunnik V.L., Tetruashvili N.K.
|
No 8 (2018) |
PECULIARITIES OF DEVELOPMENT OF DEEP-PRETERM INFANTS BY 12 MONTHS OF ADJUSTED AGE, DEPENDING ON THE RATE OF ESCALATING ENTERAL NUTRITION IN THE EARLY NEONATAL PERIOD |
|
Degtyareva A.V., Talvirskaya V.M., Amirkhanova J.Y., Narogan M.V., Ionov O.V., Kukhartseva M.V.
|
No 6 (2014) |
PELOID THERAPY IN THE REHABILITATION OF PATIENTS AFTER OVARIAN APOPLEXY |
|
ZHARKIN N.A., BUROVA N.A., KRAVCHENKO T.G.
|
No 5 (2017) |
Pelvic floor dysfunction before and after childbirth and preventive strategies in obstetric practice |
|
Kochev D.M., Dikke G.B.
|
No 11 (2017) |
Pelvic floor dysfunction in pregnant women in the third trimester |
|
Sukhanov A.A., Dikke G.B., Kukarskaya I.І.
|
No 2 (2018) |
Pelvic floor dysfunction in women: clinical presentation, diagnosis, and principles of treatment |
|
Krasnopolskaya I.V.
|
No 4 (2019) |
Pelvic floor muscle failure and impaired vaginal microbiocenosis: results of combination treatment |
|
Dikke G.B.
|
No 7-2 (2011) |
PELVIC FLOOR MYOELECTROSTIMULATION IN THE TREATMENT OF FEMALE URINARY INCONTINENCE |
|
SEROV V.N., APOLIKHINA I.A., KUBITSKAYA Y.V., ZHELEZNYAKOVA A.I.
|
No 1 (2021) |
PELVIC NERVE-SPARING SURGERY USING A WATER-JET DISSECTOR |
|
MESHKOVA M.A., MUKHTARULINA S.V., ANPILOGOV S.V., KHADZHIEVA A.I., NOVIKOVA E.G., KAPRIN A.D.
|
No 7-1 (2011) |
PELVIC PAIN-COMPLICATED CHRONIC TRIGONITIS IN EARLY-STAGE PROLAPSE IN WOMEN: PRINCIPLES OF MEDICAL TREATMENT |
|
NEIMARK A.I., SHELKOVNIKOVA N.V., RAZDORSKAYA M.V.
|
No 4 (2015) |
PENTALOGY OF CANTRELL: A CLINICAL CASE |
|
Asherova-Yushkova D.V., Krasnova L.A., Yasneva T.Z., Kocheshkov S.N., Lyashenko A.Y., Chaparova T.V., Gorodova E.V., Shmeliova A.A., Badanina Y.S., Protasova M.O.
|
No 2 (2017) |
Perinatal audit and a “neonatal near miss” model as a current form of care quality control in neonatology |
|
Bushtyrev V.A., Zubkov V.V., Kuznetsova N.B., Barinova V.V.
|
No 3 (2009) |
Perinatal infections: problems and ways of solution |
|
Savicheva A.M., Shipitsyna E.V., Savicheva A.M., Shipitsyna Y.V.
|
No 6 (2012) |
PERINATAL MORTALITY IN THE RUSSIAN FEDERATION: POSSIBLE WAYS OF ITS REDUCTION |
|
FROLOVA O.G., SHUVALOVA M.P., GREBENNIK T.K., DOLGUSHINA N.V.
|
No 1 (2025) |
Perinatal outcomes of monochorionic multigestational pregnancies with different types of selective fetal growth restriction |
|
Gladkova K.A., Frolova E.R., Sakalo V.A., Kostyukov K.V.
|
No 8 (2020) |
Perinatal outcomes of monochorionic multiple pregnancies complicated by twin-to-twin transfusion syndrome |
|
Kostyukov K.V., Sakalo V.A., Gladkova K.A., Shakaya M.N., Ionov O.V., Tetruashvili N.K.
|
No 6 (2020) |
Perinatal outcomes of monochorionic multiple pregnancies with selective intrauterine growth restriction |
|
Kostyukov K.V., Gladkova K.A.
|
No 1 (2012) |
PERINATAL OUTCOMES OF MULTIPLE BIRTHS |
|
BARANOV I.I., TOKOVA Z.Z., TADEVOSYAN A.A.
|
No 5 (2020) |
PERINATAL OUTCOMES OF TWIN PREGNANCIES WITH BIRTH WEIGHT DISCORDANCE |
|
KOSTYUKOV K.V., IONOV O.V., SHAKAYA M.N.
|
No 7 (2023) |
Perinatal outcomes of twin pregnancies with single fetal demise and different types of placentation |
|
Kostyukov K.V., Nikitina A.T., Cherepanova A.E., Gladkova K.A.
|
No 7 (2017) |
Perinatal prevention of diseases caused by Group B streptococcus (clinical protocol) |
|
Kan N.E., Tyutyunnik V.L., Dubrovina N.V., Zubkov V.V., Priputnevich T.V., Lyubasovskaya L.A., Melkumyan A.R., Lomova N.A., Shmakov R.G., Tetruashvili N.K., Sokur T.N., Klimenchenko N.I., Baev O.R., Ryumina I.I.
|
No 9 (2015) |
Perineovaginal lifting as a new solution in the treatment of genital prolapse and sexual disorders |
|
Accardo C., Apolikhina I.A., Odinokova V.A.
|
No 4 (2022) |
Periodontal diseases and their association with unwanted pregnancy outcomes |
|
Burduli A.G., Balmasova I.P., Tsarev V.N., Arutyunov S.D.
|
No 1 (2024) |
Perioperative management of pregnant women in non-obstetric surgery |
|
Nitchenko A.V., Troshin P.V., Pyregov A.V., Kozachenko I.F., Belov A.V., Filippovitch G.V., Pismensky S.V.
|
No 5 (2023) |
Perioperative sanitation of women with nonspecific vulvovaginitis and bacterial vaginosis |
|
Khashukoeva A.Z., Markova E.A., Beslangurova Z.A., Lyafisheva D.M., Shokulova Z.K.
|
No 11 (2017) |
Peripartum cardiomyopathy and clinical masks of severe preeclampsia: Issues of differential diagnosis and management tactics |
|
Ignatko I.V., Strizhakov L.A., Timokhina E.V., Afanasyeva N.V., Ryabova S.G.
|
No 6 (2016) |
Peripartum cardiomyopathy: A clinical case |
|
Shkyaev A.E., Kotelnikova O.V., Tveritnev P.M.
|
No 2 (2019) |
Peripheral blood cytokine levels in women according to the phase of the first period of labor |
|
Tysyachnyy O.V., Pavlova O.A., Vtorushina V.V., Krechetova L.V., Baev O.R.
|
No 1 (2025) |
Peripheral blood nk cells in patients with uterine scars and abnormally adherent and invasive placenta |
|
Ponikarova N.Y., Davydova A.A., Shelepova E.S., Osipova N.A., Sokolov D.I., Mikhailova V.A., Oganyan K.A., Selkov S.A., Zazerskaya I.E.
|
No 9 (2022) |
Peripheral blood NK-cells in women with unsuccessful attempts of assisted reproduction: quantity, subpopulation composition and activation markers |
|
Zagaynova V.A., Kogan I.Y., Selkov S.A., Bespalova O.N., Krikheli I.O., Mikhailova V.A., Davydova A.A., Milyutina Y.P., Sokolov D.I.
|
No 9 (2022) |
Peritoneal inclusion cyst |
|
Ivanova L.B., Valiev R.K., Davydova I.Y., Loginova E.A., Dymova A.V., Chistova E.Y.
|
No 1 (2025) |
Personalised medicine in action: lipidomic markers for predicting premature rupture of membranes |
|
Baisova A.R., Amiraslanov E.Y., Frankevich V.E., Chagovets V.V., Tokareva A.O., Tyutyunnik V.L.
|
No 5 (2015) |
PERSONALIZED APPROACH TO USING MIFEPRISTONE IN PATIENTS WITH UTERINE MYOMA |
|
Kareva E.N., Bekhbudova L.K., Gorenkova O.S., Samoilova T.E.
|
No 8 (2019) |
PERSONALIZED MEDICINE AND MODERN SURGICAL TECHNOLOGIES |
|
Volkov O.A., Shramko S.V., Bagenova L.G.
|
No 4 (2023) |
Personnel management in a medical organization: modern tools and technologies |
|
Avdeeva O.V., Minakova E.N., Goloshubov P.A., Verkhovtsev A.A., Kaverina E.V., Nikolaeva A.V.
|
No 5 (2010) |
PERSPECTIVES FOR THE FORMATION OF NATIONAL LEGISLATION IN REPRODUCTIVEHEALTH IN THE RUSSIAN FEDERATION |
|
sukhikh G.T., YuSUPOVA A.N., PAVLOVA Y.V., EROFEEVA L.V., Sukhikh G.T., Yusupova A.N., Pavlova Y.V., Yerofeyeva L.V.
|
No 10 (2018) |
Pharmaceutical formulation and investigations of sustained-release paracetamol matrix tablets and their potential antipyretic effect in children |
|
Dyatlov N.A.
|
No 6 (2018) |
Pharmacoeconomic analysis of infertility treatment in women with a suboptimal ovarian response |
|
Yagudina R.I., Kulikov A.Y., Krylov V.A.
|
No 3 (2018) |
Pharmacoeconomic analysis of the use of oral iron preparations for the treatment and prevention of iron-deficiency anemia in pregnancy |
|
Gribkova I.V., Kholovnya-Voloskova M.E., Polyakova K.I., Stepanova.N V.N., Dubovtseva V.A., Fisun A.G., Davydovskaya M.V., Ermolaeva T.N.
|
No 2 (2008) |
Pharmacoepidemiological studies in obstetrics |
|
Chilova R.A., Ishchenko A.I., Rafalsky V.V., Strachunsky L.S.
|
No 12 (2022) |
Pharmacogenetic approach to managing women with an unpredictable poor response to ovarian stimulation in the in vitro fertilization program |
|
Perminova S.G., Belova I.S., Donnikov A.E.
|
No 10 (2015) |
Pharmacogenetic approach to preventing folate deficiency: L-5-methyltetrahydrofolate or folic acid? |
|
Donnikov A.E.
|
No 2 (2020) |
Pharmacogenetic approaches to hypertension treatment in pregnant women |
|
Shikh E.V., Zhukova O.V., Ostroumova O.D., Sharonova S.S.
|
No 8 (2022) |
Pharmacokinetic properties and safety assessment of the generic vaginal gel progesterone preparation: results of an open-label, randomized, crossover bioequivalence study |
|
Tapilskaya N.I., Gzgzyan A.M., Kogan I.Y., Pisarev V.V., Merkulov M.E., Korneeva I.E.
|
No 2 (2011) |
PHARMACOLOGICAL CORRECTION OF ADMA-ENOS-ASSOCIATED TARGETS IN PREECLAMPSIA |
|
POKROVSKY M.V., POKROVSKAYA T.G., GUREYEV V.V., BARSUK A.A., PROSKURYAKOVA E.V., KOROKIN M.V., BELOUS A.S., KOROKINA L.V., RAGULINA V.A., GUDYREV O.S., LEVASHOVA O.V., KOROLEV A.E., MALTSEVA N.V., POLYANSKAYA O.S., TEREKHOVA E.G., BABKO A.V., NOVIKOV O.O., ZHILYAKOVA E.T., SOROKOPUDOV V.N., KOLESNIK I.M.
|
No 4 (2014) |
Pharmacological correction of iron and magnesium deficiencies during pregnancy: Current approaches |
|
Mubarakshina O.A., Somova M.N., Lyubavskaya S.S.
|
No 12 (2015) |
PHARMACOLOGICAL CORRECTION OF IRON-DEFICIENCY ANEMIA DURING PREGNANCY |
|
Batishcheva G.A., Mubarakshina O.A., Somova M.N., Mubarakshin E.A., Barbashina K.V.
|
No 6 (2016) |
Pharmacotherapy for heartburn during pregnancy: Safety of reserve drugs |
|
Chukhareva N.A., Kartseva V.S., Esayan R.M., Ushkalova E.A., Tkacheva O.N., Bevz A.Y., Povetkin S.V., Chizhova G.V., Panova I.A., Bontsevich R.A., Vinogradova N.G., Pribytkova O.V., Feoktistova Y.V.
|
No 4 (2010) |
Pharmacotherapy for massive obstetric hemorrhage |
|
MOMOT A.P., MOLChANOVA I.V., TsKhAY V.B., Momot A.P., Molchanova I.V., Tskhai B.V.
|
No 9 (2013) |
PHARMACOTHERAPY FOR UNCOMPLICATED INFLAMMATORY DISEASES OF SMALL PELVIC ORGANS |
|
LEVAKOV S.A., KEDROVA A.G., CHELNOKOVA N.N.
|
No 5 (2011) |
PHENOTYPIC AND FUNCTIONAL CHARACTERISTICS OF NK CELLS IN PREGNANCY |
|
MIKHAYLOVA V.A., SELKOV S.A., SOKOLOV D.I.
|
No 10 (2021) |
Phenotypic characterization of peripheral blood innate immune cell subpopulations in women with endometriosis before and after surgery |
|
Korotkova T.D., Krechetova L.V., Inviyaeva E.V., Vtorushina V.V., Vanko L.V., Adamyan L.V.
|
No 5 (2023) |
Phenotypic profile of peripheral blood mononuclear cells in preeclampsia |
|
Krasnyi A.M., Kan N.E., Mirzabekova D.D., Tyutyunnik V.L., Panasenko E.A., Sadekova A.A.
|
No 2 (2008) |
Photodynamic therapy in the treatment of abnormalities of the cervix uteri and endothelium |
|
Khashukoyeva A.Z., Makarov O.V., Otdelnova O.B., Rekhviashvili S.A.
|
No 1 (2015) |
Photodynamic therapy: A new approach to treating human papillomavirus-associated cervical pathology |
|
Trushina O.I., Novikova E.G.
|
No 5 (2025) |
Phylogenetic and ontogenetic role of placenta decidua in establishing pregnancy and specific characteristics of its course |
|
Lipatov I.S., Tezikov Y.V., Kalinkina O.B., Kurbanova A.M., Tarasov D.O., Mikhailova E.I., Dubinsky M.R.
|
No 1 (2022) |
Physical activity and stress urinary incontinence: versions and contraversions |
|
Korotkevich O.S., Mozes V.G., Mozes K.B., Eizenakh I.A.
|
No 11 (2015) |
PHYSICAL AND PSYCHOMOTOR DEVELOPMENT IN INFANTS WITH INTRAUTERINE GROWTH RETARDATION |
|
Kirillova E.A.
|
No 5 (2025) |
Physical factors in the early postpartum period in an obstetric unit |
|
Malanova T.B., Ipatova M.V., Kubitskaya Y.V., Nikolaeva A.V., Ignatyeva A.A.
|
No 3 (2010) |
Physiological bases of regulation of uterine contractility |
|
Kovalev V.V., Tsyv'yan P.B., Milyaeva N.M., Lukin O.N., Protsenko Y.L., Kovalev V.V., Tsyvyan P.B., Milyaeva N.M., Lukin O.N., Protsenko Y.L.
|
No 8 (2014) |
Physiotherapeutic approaches to preventing and treating complications after artificial abortion in the first trimester |
|
Ipatova M.V., Malanova T.B., Kubitskaya Y.V.
|
No 5 (2012) |
PHYTOESTROGENS: WHAT IS KNOWN TODAY |
|
RAFAELYAN I.V., BALAN V.E., KOVALEVA L.A.
|
No 9 (2020) |
Phytopreparations based on cimicifuga root extract for relieving menopausal symptoms |
|
Mubarakshina O.A., Somova M.N., Batishcheva G.A., Mubarakshin E.A.
|
No 1 (2012) |
PLACE OF ABDOMINAL AND VAGINAL SURGICAL DELIVERY IN MODERN OBSTETRICS. REALITY AND PROSPECTS |
|
KRASNOPOLSKY V.I., LOGUTOVA L.S., PETRUKHIN V.A., BUYANOVA S.N., POPOV A.A., CHECHNEVA M.A., AKHVLEDIANI K.N., TSIVTSIVADZE E.B., MELNIKOV A.P.
|
No 10 (2013) |
PLACE OF LACTOFLORA IN THE CORRECTION OF IMPAIRED VAGINAL MICROBIOCENOSIS IN SEXUALLY ACTIVE WOMEN |
|
CHERNOVA N.I., PERLAMUTROV Y.N.
|
No 3 (2024) |
Placenta Accreta Spectrum: experience of the surgical treatment |
|
Rymashevsky A.N., Volkov A.E., Kantsurova M.R.
|
No 1 (2024) |
Placenta accreta: a modern view on etiopathogenesis and obstetric tactics |
|
Ignatko I.V., Bogomazova I.M., Timokhina E.V., Belousova V.S., Fedyunina I.A., Kardanova M.A., Samara A.B., Gutsu V.
|
No 5 (2009) |
Placenta and its status in varicosity disease in multiparas |
|
Omarova K.M.
|
No 1 (2020) |
Placenta in pregnant women with chronic kidney disease |
|
Barinova I.V., Nikolskaya I.G., Kotov Y.B., Prokopenko E.I., Kondrikov N.I.
|
No 6 (2021) |
Placenta increta. Evolution of knowledge and skills |
|
Lisitsyna O.I., Nizyaeva N.V., Mikheeva A.A.
|
No 5 (2019) |
Placenta previa and increta into the lower segment myometrium and cervical canal with uterine artery aneurysm in pregnant women with no uterine scar |
|
Tskhai V.B., Glyzina Y.N., Yametov P.K., Levanova E.A., Lobanova T.T., Gritzaeva E.A., Chubko M.A.
|
No 5 (2019) |
Placental angioarchitecture in monochorionic twin pregnancies with twin-twin transfusion syndrome. Perinatal outcomes |
|
Bugerenko A.E., Sukhanova D.I., Donchenko Y.S., Panina O.B., Sichinava L.G.
|
No 3 (2015) |
Placental apoptosis and antioxidant defense enzyme gene expression in preeclampsia |
|
Sukhikh G.T., Krasnyi A.M., Kan N.E., Maiorova T.D., Tyutyunnik V.L., Khovkhaeva P.A., Sergunina O.A., Tyutyunnik N.V., Gracheva M.I., Vavina O.V., Ozernyuk N.D., Boris D.A.
|
No 9 (2018) |
Placental dysfunction in HIV-infected pregnant women |
|
Voevodin S.M., Shemanayeva T.V., Shchegolev A.I., Parkhomenko Y.G.
|
No 12 (2016) |
PLACENTAL EPITHELIAL-MESENCHYMAL TRANSITION IN PREECLAMPSIA |
|
Vishnyakova P.A., Tarasova N.V., Volodina M.A., Marey M.V., Khodzhaeva Z.S., Kan N.E., Vysokikh M.Y.
|
No 7 (2018) |
Placental expression level of the PON1, PON2, and PON3 genes in patients with uncomplicated pregnancy and preeclampsia |
|
Antipova N.V., Levakov S.A., Sheshukova N.A., Obukhova E.A., Pavlyukov M.S., Shakhparonov M.I.
|
No 12 (2023) |
Placental hemangioma |
|
Frolova E.A., Tumanova U.N., Shchegolev A.I.
|
No 3 (2022) |
Placental inflammatory changes associated with mRNA expression of transcription factor genes in term pregnancy |
|
Kaganova M.A., Spiridonova N.V.
|
No 4 (2008) |
Placental insufficiency and miscarriage in patients with chronic viral infections: Immunological aspects |
|
Dolgushina N.V.
|
No 10 (2021) |
Placental insufficiency in pregnant women with high body mass index and without gestational diabetes |
|
Datsenko N.S., Volchek A.V., Yakimova A.V., Pozdnyakov I.M., Ageeva T.A., Marinkin I.O., Aidagulova S.V.
|
No 3 (2013) |
PLACENTAL INSUFFICIENCY IN PREGNANT WOMEN WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA |
|
KAN N.E., KLIMANTSEV I.V., DUBOVA E.A., AMIRASLANOV E.Y., SANNIKOVA M.V., SERGUNINA O.A., PAVLOV K.A., SHCHEGOLEV A.I., TYUTYUNNIK V.L.
|
No 12 (2020) |
Placental lesions in pregnant women with SARS-CoV-2 infection |
|
Shchegolev A.I., Tumanova U.N., Serov V.N.
|
No 5 (2010) |
PLACENTAL MESENCHYMAL DYSPLASIA |
|
PAVLOV K.A., DUBOVA E.A., ShchEGOLEV A.I., Pavlov K.A., Dubova E.A., Shchegolev A.I.
|
No 5 (2017) |
PLACENTAL MITOCHONDRIA IN HEALTH AND IN PREECLAMPSIA |
|
VISHNYAKOVA P.A., KAN N.E., KHODZHAEVA Z.S., VYSOKIKH M.Y.
|
No 10 (2018) |
Placental mosaicism for chromosome 7 detected by genome-wide noninvasive DMA screening for fetal aneuploidies from maternal blood |
|
Barkov I.Y., Shubina E., Stupko O.K., Kim L.V., Tetruashvili N.K., Ekimov A.N., Lyapin V.M., Klimenchenko N.I., Sokur T.N., Karetnikova N.A., Bystritsky A.A., Mullabaeva S.M., Trofimov D.Y., Sukhikh G.T.
|
No 7 (2022) |
PLACENTAL MOSAICISM IN PREGNANCIES AT HIGH RISK FOR TRISOMY 16 ACCORDING TO GENOME-WIDE DNA-BASED NONINVASIVE PRENATAL SCREENING FOR ANEUPLOIDIES |
|
BARKOV I.Y., SHUBINA J., KIM L.V., BOLSHAKOVA A.S., TROFIMOV D.Y., GOLTSOV A.Y., SADELOV I.O., PARSADANYAN N.G., BULATOVA Y.S., TETRUASHVILI N.K.
|
No 3 (2014) |
PLACENTAL PATHOLOGY IN FETAL CHROMOSOME ABNORMALITIES |
|
ANDRONOVA N.V., ZARETSKAYA N.V., KHODZHAEVA Z.S., SHCHEGOLEV A.I., KHRAMCHENKO N.V., VOEVODIN S.M.
|
No 7 (2017) |
Placental PIBF1 gene mRNA expression during preterm labor |
|
Dobrokhotova Y.E., Trofimov D.Y., Shchegolev A.I., Burmenskaya O.V., Veselovskaya Y.S., Mitrofanova Y.V., Olenev A.S., Pastarnak A.Y., Gogichaev T.K.
|
No 5 (2025) |
Placental programming of neuropsychiatric disorders. postnatal neurological consequences of preeclampsia |
|
Nikitina N.A., Sidorova I.S., Amiraslanova N.I., Ageev M.B., Gololobova М.N.
|
No 7 (2013) |
PLACENTAL PROTEOMIC PROFILE DURING PHYSIOLOGICAL AND PREECLAMPSIA-COMPLICATED PREGNANCY |
|
POGORELOVA T.N., GUNKO V.O., LINDE V.A.
|
No 11 (2019) |
Placental ultrastructural and immunohistochemical changes in preeclampsia with concomitant fetal growth restriction |
|
Nizyaeva N.V., Amiraslanov E.Y., Lomova N.A., Pavlovich S.V., Savel’eva N.A., Nagovitsyna M.N., Sukhacheva T.V., Serov R.A., Shchegolev A.I., Kan N.E.
|
No 5 (2022) |
Placental vessel thrombosis as a cause of antenatal fetal death in pregnant women with novel coronavirus infection |
|
Malgina G.B., Grishkina A.A., Dyakova M.M., Bychkova S.V., Chistyakova G.N., Pepelyaeva N.A., Melkozerova O.A., Bashmakova N.V., Pestryaeva L.A.
|
No 2 (2021) |
PLACENTA-SPECIFIC MICRO-RNA EXPRESSION IN FETAL GROWTH RESTRICTION |
|
Bushtyreva I.O., Kuznetsova N.B., Zabanova E.A., Butenko E.V., Pokudina I.O., Shkurat T.P.
|
No 3 (2015) |
Plasma and peritoneal fluid IL-1β, IL-8, and substance P levels in patients with different forms of external genital endometriosis and chronic pelvic pain |
|
Ovakimyan A.S., Krechetova L.V., Vtorushina V.V., Vanko L.V., Kozachenko I.F., Adamyan L.V.
|
No 8 (2021) |
Plasma cytokine level changes in preterm neonates with respiratory disorders in the early neonatal period |
|
Nikitina I.V., Inviyaeva E.V., Krog-Jensen O.A., Vtorushina V.V., Lenyushkina A.A., Krechetova L.V., Zubkov V.V., Degtyarev D.N.
|
No 8 (2021) |
Plasma cytokine profiles in preterm neonates with congenital pneumonia in the first week of life |
|
Inviyaeva E.V., Nikitina I.V., Krechetova L.V., Krog-Jensen O.A., Vtorushina V.V., Lenyushkina A.A., Zubkov V.V., Degtyarev D.N.
|
No 9 (2020) |
Plasma hemostatic system in patients with the novel coronavirus disease 2019 (COVID-19) |
|
Markelov M.I., Beznoshchenko O.S., Ivanets T.Y., Pyregov A.V., Esayan R.M., Gavrilova T.Y., Krechetova L.V.
|
No 11 (2023) |
Plasma levels of cell adhesion molecules in normal pregnancy and preeclampsia |
|
Shelekhin A.P., Baev O.R., Andreev Y.V., Sadekova A.A., Krasnyi A.M.
|
No 6 (2020) |
Plasma levels of soluble E-cadherin and the keratinocytes growth factor in intrauterine growth restriction |
|
Krasnyi A.M., Khachaturyan A.A., Vtorushina V.V., Krechetova L.V., Kan N.E., Tyutyunnik V.L.
|
No 2 (2019) |
Plasma levels of transforming growth factor p isoforms in women with preeclampsia |
|
Vtorushina V.V., Kharchenko D.K., Krechetova L.V., Astashkin E.I., Kan N.E.
|
No 5 (2023) |
Plasma proteome cluster analysis in pregnant women with preeclampsia |
|
Nikitina N.A., Sidorova I.S., Ziganshin R.K., Kir'yanova M.A., Ageev M.B.
|
No 5 (2021) |
Plasma TLR2 and IGF2/H19 imprinting control region gene methylation in fetal growth restriction |
|
Kan N.E., Tyutyunnik V.L., Khachatryan Z.V., Sadekova A.A., Krasnyi A.M.
|
No 1 (2010) |
Plasmapheresis and immunoglobulin therapy in the complex treatment of rhesus sensitization |
|
Fedorova T.A., Mitrya I.V.
|
No 9 (2023) |
Platelet activation by seminal plasma components in the induction of mechanisms of immunological tolerance in pregnancy |
|
Zhukova A.S., Nikolaeva M.A., Krechetova L.V.
|
No 6 (2023) |
Platelet function and blood clotting during normal pregnancy |
|
Safiullina S.I., Evtugina N.G., Peshkova A.D., Litvinov R.I.
|
No 5 (2015) |
Plenum of the Presidium of the Russian Society of Obstetricians and Gynecologists Unniversary |
|
- -.
|
No 9S (2019): Supplement |
PODGOTOVKA ENDOMETRIYa K PERENOSU RAZMOROZhENNYKh EMBRIONOV |
|
Syrkasheva A.G., Petrosyan Y.A., Kalinina E.A.
|
No 3 (2021) |
Polycystic ovary syndrome and gut microbiota |
|
Chernukha G.E., Miroshina E.D., Priputnevich T.V.
|
No 9 (2017) |
Polycystic ovary syndrome and pregnancy |
|
Ananyev E.V.
|
No 12 (2018) |
Polycystic ovary syndrome in adolescents suffering from excessive body weight and insulin resistance |
|
Khashchenko E.P., Vysokikh M.Y., Batyrova Z.K., Kumykova Z.K., Uvarova E.V., Ivanetc T.Y., Tsvirkun D.V., Vtorushina V.V.
|
No 11 (2020) |
Polycystic ovary syndrome in the presence of undifferentiated connective tissue dysplasia |
|
Tereshchenko I.V.
|
No 3 (2020) |
Polycystic ovary syndrome: computer program-assisted diagnosis based on clinical and anamnestic factors and hormonal and ultrasound markers |
|
Beglova A.Y., Elgina S.I.
|
No 4 (2017) |
Polycystic ovary syndrome: Proteomic aspects |
|
Podzolkova N.M., Koloda Y.A.
|
No 6 (2017) |
POLYMICROBIAL ASSOCIATIONS IN THE ETIOLOGY OF INFLAMMATORY DISEASES OF THE FEMALE GENITAL ORGANS |
|
Dikke G.B.
|
No 10 (2018) |
Polymorphic LHCGR gene loci associated with the development of uterine fibroids |
|
Ponomarenko I.V., Polonikov A.V., Churnosov M.I.
|
No 9 (2019) |
Polymorphism of genes regulating the vitamin D hormonal system, and optimization of vitamin D intake in women with preeclampsia and a high risk for its development |
|
Maltseva L.I., Vasilyeva E.N., Denisova T.G., Kravtsova O.A.
|
No 12 (2019) |
Polymorphism of the CYP11A1, CYP17A1, and CYP19A1 genes in reproductive-aged women with polycystic ovary syndrome |
|
Beglova A.Y., Elgina S.I., Gordeeva L.A.
|
No 3 (2022) |
Polymorphisms of folate cycle enzyme genes: prevalence, relationships to the plasma level of homocysteine, folic acid, and vitamin B12 |
|
Shikh E.V., Putintseva A.V.
|
No 1 (2013) |
POLYMORPHISMS OF GENES INVOLVED IN FOLATE METABOLISM AND PARAMETRS OF ENDOTHELIAL FUNCTION IN EARLY PREGNANCY: RISK FACTORS FOR DEVELOPMENT OF GESTATIONAL COMPLICATIONS |
|
GAZIEVA I.A., CHISTYAKOVA G.N., KOVALEV V.V.
|
No 9 (2016) |
POLYNEOPLASIA OF FEMALE REPRODUCTIVE ORGANS AND HEREDITY |
|
Payanidi Y.G., Zhordania K.I., Pauker V., Selchuk V.Y., Kazubskaya T.P.
|
No 9 (2014) |
Poor ovarian response in assisted reproductive technology programs: An association with autoimmune ovarian lesion |
|
Vanyan R.E., Menzhinskaya I.V., Dolgushina N.V., Kalinina E.A.
|
No 9 (2013) |
POOR OVARIAN RESPONSE IN IVF PROGRAMS |
|
TETERINA I.V., VANYAN R.E., KALININA E.A., DOLGUSHINA N.V.
|
No 5 (2009) |
Poor predictors of the HLA system in married couples with habitual early miscarriages |
|
Petrosyan L.A., Faizullin L.Z., Karnaukhov V.N.
|
No 2 (2023) |
Portal vein thrombosis while taking a combined oral contraceptive after experienced coronavirus infection |
|
Shklyaev A.E., Fatkhieva A.R., Bessonov A.G., Meleshkina M.V., Zykov S.Y.
|
No 1 (2015) |
Possibilities and prospects for the use of spasmolytic agents in dysmenorrhea: Results of an international study |
|
Unanyan A.L., Arakelov S.E., Polonskaya L.S., Afanasyev M.S.
|
No 5 (2022) |
Possibilities for increasing the effectiveness of assisted reproductive technology programs using cumulus-oocyte complex-induced sperm selection |
|
Chistyakova A.V., Makarova N.P., Lobanova N.N., Smolnikova V.Y.
|
No 3 (2013) |
POSSIBILITIES FOR MEDICAL PREVENTION OF OVARIAN HYPERSTIMULATION SYNDROME |
|
FETISOVA S.V., KORNEEVA I.E.
|
No 9 (2014) |
Possibilities for noninvasive oocyte and embryo evaluation when implementing assisted reproductive technology programs for follicular-fluid growth factor mRNA expression |
|
Smolnikova V.Y., Kalinina E.A., Krasnoshchoka O.E., Donnikov A.E., Burmenskaya O.V., Trofimov D.Y., Sukhikh G.T.
|
No 11 (2019) |
Possibilities for predicting recurrent uterine myoma by plasma lipidomic analysis |
|
Tonoyan N.M., Tokareva A.O., Chagovets V.V., Starodubtseva N.L., Kozachenko I.F., Adamyan L.V., Frankevich V.E.
|
No 9 (2022) |
Possibilities for predicting the effectiveness of assisted reproductive technology programs |
|
Martynova A.E.
|
No 6 (2011) |
POSSIBILITIES FOR PREDICTION OF PREECLAMPSIA |
|
GREBENNIK T.K., PAVLOVICH S.V.
|
No 11 (2016) |
POSSIBILITIES FOR REDUCING BIRTH TRAUMA IN WOMEN AT HIGH RISK FOR MATERNAL PASSAGE SOFT TISSUE INJURIES |
|
Selikhova M.S., Vdovin S.V., Agabekan N.V.
|
No 4 (2015) |
POSSIBILITIES FOR REDUCING THE RISK OF PRETERM BIRTH IN THE CONTEXT OF EVIDENCE-BASED MEDICINE |
|
Aganezov S.S., Aganezova N.V.
|
No 9 (2016) |
POSSIBILITIES FOR SURGICAL CORRECTION OF ISTHMICOCERVICAL INSUFFICIENCY IN FETAL BLADDER PROLAPSE |
|
TSKHAI V.B.
|
No 12 (2020) |
Possibilities for systemic enzyme therapy in patients with chronic endometritis after missed abortion |
|
Ordiyants I.M., Kogan Y.A., Barabasheva S.S., Molchanova O.K.
|
No 5 (2014) |
Possibilities for the treatment of iron-deficiency anemia in third-trimester pregnancy |
|
Petrukhin V.A., Melnikov A.P., Budykina T.S., Grishin V.L.
|
No 4 (2013) |
POSSIBILITIES FOR THERAPY OF A COMORBIDITY OF UTERINE MYOMA AND BENIGN BREAST DYSPLASIAS |
|
RADZINSKY V.E., ORDIYANTS I.M., MASLENNIKOVA M.N., PAVLOVA E.A., KARDANOVA V.V.
|
No 2 (2021) |
POSSIBILITIES OF 3D MODELING OF THE UTERINE CAVITYIN THE DIAGNOSIS OF EARLY HYPOTONIC BLEEDING |
|
Ziganshin A.M., Mudrov V.A., Pekarev O.G., Kulavsky E.V.
|
No 10 (2019) |
Possibilities of a combined approach to treating endometriosis-associated infertility |
|
Artymuk N.V., Danilova L.N., Tachkova O.A.
|
No 1 (2022) |
Possibilities of alternative pharmacological approaches to monotherapy for bacterial vaginosis in reproductive-aged patients |
|
Lebedenko E.Y., Gaida O.V., Mikhailenko Y.V., Anufrieva V.G., Rymashevsky M.A., Sablina N.V., Bespalaya A.V.
|
No 5 (2024) |
Possibilities of antibacterial therapy in patients with mixed infections of the vagina and cervix: the results of the Flora Centrum study |
|
Apolikhina I.A., Boris D.A., Iurova M.V., Gorbunova E.A., Teterina T.A.
|
No 2 (2014) |
Possibilities of argon plasma coagulation in the combination therapy of severe endometriosis |
|
Glukhov E.Y., Oboskalova T.A., Urakov A.V.
|
No 4-1 (2012) |
POSSIBILITIES OF COMBINATION TREATMENT FOR CHRONIC CERVICITIS |
|
DOVLETKHANOVA E.R., ABAKAROVA P.R.
|
No 10 (2024) |
Possibilities of correction of the endometrial receptor profile in chronic endometritis |
|
Tolibova G.K., Tral T.G., Kakhiani M.I.
|
No 5 (2019) |
Possibilities of echography in determining the weight of an extreme large fetus |
|
Derkatch E.A., Guseva O.I.
|
No 8 (2020) |
Possibilities of geometric modeling in reducing the error of calculating true conjugate of pelvic cavity |
|
Mudrov V.A.
|
No 6 (2011) |
POSSIBILITIES OF HORMONAL THERAPY FOR FEMALE UROGENITAL ATROPHY |
|
BALAN V.E., KOVALEVA L.A., AMIROVA Z.S., RAFAELYAN I.V.
|
No 12 (2014) |
Possibilities of increasing therapy adherence in patients with papillomavirus infection |
|
Tsallagova E.V.
|
No 10 (2016) |
POSSIBILITIES OF LOW-DOSE LOCAL ESTRIOL THERAPY IN POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY |
|
Glazunova A.V., Yureneva S.V., Yezhova L.S., Ermakova E.I., Yeprikyan E.G.
|
No 2 (2010) |
Possibilities of medical treatment for female stress urinary incontinence |
|
Zheleznyakova A.I., Apolikhina I.A., Ibinaeva I.S., Zheleznyakova A.I., Apolikhina I.A., Ibinayeva I.S.
|
No 10 (2013) |
POSSIBILITIES OF METHODS FOR EVALUATING THE UTERINE WALL AFTER CESAREAN SECTION |
|
PRIKHODKO A.M., BAYEV O.R., LUNKOV S.S., EREMINA O.V., GUS A.I.
|
No 5 (2018) |
Possibilities of non-invasive post-genomics technologies in the prediction and early diagnosis of preeclampsia |
|
Muminova K.T.
|
No 7 (2018) |
Possibilities of organ-sparing surgery for adenomyosis in the context of reproductive function preservation |
|
Rukhlyada N.N., Krylov K.Y., Biryukova E.I.
|
No 5 (2011) |
POSSIBILITIES OF PHYTOTHERAPY FOR URINARY TRACT INFECTION IN OBSTETRIC PRACTICE |
|
KHILKEVICH E.G.
|
No 2 (2013) |
POSSIBILITIES OF PREDICTING AND PREVENTING COMPLICATIONS IN COMBINED IMPAIRMENTS IN THE COAGULANT AND ANTICOAGULANT COMPONENTS OF THE HEMOSTATIC SYSTEM IN OBSTETRIC PRACTICE |
|
KIRYUSHCHENKOV P.A., KOVALEV M.V., TAMBOVTSEVA M.A.
|
No 3 (2021) |
Possibilities of predicting preterm birth using mitochondrial DNA and VDAC1 protein |
|
Tyutyunnik V.L., Kan N.E., Vysokikh M.Y., Kokoeva D.N., Donnikov A.E., Saribekova A.G., Medzhidova M.K.
|
No 2 (2012) |
POSSIBILITIES OF PREDICTING THE OUTCOMES OF ASSISTED REPRODUCTIVE TECHNOLOGIES FROM SPERM mRNA LEVELS |
|
SMOLNIKOVA V.Y., KRASNOSHCHOKA O.E., BURMENSKAYA O.V., TROFIMOV D.Y., KALININA E.A., SUKHIKH G.T.
|
No 11 (2020) |
Possibilities of predicting the outcomes of assisted reproductive technology programs in patients with ovarian endometrioid cysts on the basis of the metabolic profile of follicular fluid |
|
Nikolenko I.G., Smolnikova V.Y., Chagovets V.V.
|
No 8 (2016) |
Possibilities of preimplantation genetic diagnosis in enhancing the efficiency of IVF/ICSI programs in married couples with male factor infertility and male genetic traits |
|
Belyaeva N.A., Kalinina E.A., Gorshinova V.K., Zobova A.V., Glinkina J.I.
|
No 10 (2018) |
Possibilities of reproduction after treatment for early endometrial cancer |
|
Pronin S.M., Matsneva I.A., Novikova E.G.
|
No 6 (2024) |
Possibilities of the biologically active complex of phytopreparations in the correction of menopausal disorders |
|
Yashchuk A.G., Dautova L.A., Shaikhutdinova O.V., Muslimova L.R., Berg P.A., Berg E.A., Nasyrova S.F., Kizko I.A., Nazyrova A.G.
|
No 9 (2013) |
POSSIBILITIES OF THE DIAGNOSIS AND TREATMENT OF THE CERVIX UTERI |
|
PRILEPSKAYA V.N., KOGAN E.A., TROFIMOV D.Y.
|
No 7 (2013) |
POSSIBILITIES OF THE ULTRASOUND DIAGNOSIS OF FETAL GASTROINTESTINAL TRACT MALFORMATIONS. PART 1 |
|
DEMIDOV V.N., MASHINETS N.V.
|
No 8 (2013) |
POSSIBILITIES OF THE ULTRASOUND DIAGNOSIS OF FETAL GASTROINTESTINAL TRACT MALFORMATIONS. (PART 2, INTESTINE DEVELOPMENTAL ANOMALIES) |
|
DEMIDOV V.N., MASHINETS N.V.
|
No 6 (2017) |
POSSIBILITIES OF THERAPY FOR HPV-ASSOCIATED CHRONIC CERVICITIS IN WOMEN |
|
Maltseva L.I., Farrakhova L.N.
|
No 5 (2011) |
POSSIBILITIES OF THERAPY FOR HPV-ASSOCIATED GENITAL DISEASES IN WOMEN |
|
PRILEPSKAYA V.N., DOVLETKHANOVA E.R., ABAKAROVA P.R.
|
No 10 (2020) |
Possibilities of threedimensional echography in the diagnosis of Mullerian duct anomalie |
|
Esipova I.A., Krasnova I.A., Breusenko V.G.
|
No 10 (2020) |
Possibilities of ultrasonic shear wave elastography in the diagnosis of cervical cancer (first experience) |
|
Zykin B.I., Ogryzkova V.L., Ionova E.A.
|
No 1 (2021) |
POSSIBILITIES OF USING HIGH-INTENSITY FOCUSED ULTRASOUND THERAPY IN PATIENTS WITH ENDOMETRIOSIS |
|
MOSKVICHEVA L.I.
|
No 5 (2022) |
Possibilities of using photodynamic therapy in the treatment of cervical precancers and cancers |
|
Gilyadova A.V., Ishchenko A.A., Apolikhina I.A., Saidova A.S., Shiryaev A.A., Samoilova S.I., Alekseeva P.M., Efendiev K.T., Reshetov I.V.
|
No 4 (2017) |
Possibilities of using some autoantibodies in the diagnosis of preeclampsia |
|
Malsagova A.A., Tsakhilova S.G., Sarakhova J.H., Khmelnitskaya A.V., Begizova A.M., Poletaev A.B.
|
No 6 (2011) |
POSSIBILITIES OF USING VIBROMAGNETIC PHYSIOTHERAPY IN THE TREATMENT OF BACTERIAL VAGINOSIS IN WOMEN |
|
CHURAKOV A.A., RAIGORODSKY Y.M., GELYAKHOVA Z.A., KONOVA A.N.
|
No 6 (2015) |
POSSIBILITY FOR THE PREDICTION AND EARLY DIAGNOSIS OF PREECLAMPSIA FROM THE URINARY PEPTIDE PROFILE |
|
Starodubtseva N.L., Bugrova A.E., Kononikhin A.S., Vavina O.V., Shirokova V.A., Naumov V.A., Garanina I.A., Lagutin V.V., Popov I.A., Loginova N.S., Khodjaeva Z.S., Frankiewicz V.E., Nikolaev E.N., Sukhikh G.T.
|
No 4 (2025) |
Possibility of using microRNA in non-invasive diagnosis of endometriosis |
|
Yarmolinskaya M.I., Cherkashina S.A., Malysheva O.V.
|
No 5 (2015) |
POSSIBLE CAUSES OF BIRTH-RELATED BRACHIAL PLEXUS INJURY |
|
Khusainov N.O., Oreshkov A.B.
|
No 10 (2021) |
Possible molecular and biological mechanisms for the development of selective fetal growth restriction in monochorionic twin pregnancy |
|
Neftereva A.A., Sakalo V.A., Gladkova K.A., Kostyukov K.V., Khodzhaeva Z.S.
|
No 7 (2023) |
Possible predictors of recurrence risk of deep endometriosis |
|
Senina D.N., Chuprynin V.D., Asaturova A.V., Chursin V.V., Buralkina N.A.
|
No 6 (2023) |
Postcovid syndrome in pregnant women |
|
Belokrinitskaya T.E., Frolova N.I., Mudrov V.A., Kargina K.A., Shametova E.A., Agarkova M.A., Zhamiyanova C.T.
|
No 12 (2023) |
Post-COVID syndrome in pregnant women with a history of mild and moderate COVID-19 |
|
Malgina G.B., Dyakova M.M., Bychkova S.V., Shikhova E.P., Klimova L.E.
|
No 7 (2023) |
Post-COVID-19 syndrome in early reproductive age women |
|
Belokrinitskaya T.E., Frolova N.I., Mudrov V.A., Kargina K.A., Shametova E.A., Zhamyanova C.T., Osmonova S.R.
|
No 1 (2017) |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME DURING ATYPICAL PREECLAMPSIA AND ECLAMPSIA |
|
SHALINA R.I., KURTSER M.A., SHTABNITSKY A.M., KURGANSKAYA M.A., PLATITSYN I.V.
|
No 1 (2014) |
Posterior reversible encephalopathy syndrome (PRES) caused by hypertensive encephalopathy and acute uremia in a parturient: a clinical case |
|
Tyutyunnik V.L., Kan N.E., Bychenko V.G., Kulabukhova E.A., Voevodin S.M., Anoshin A.S.
|
No 12 (2024) |
Postexcision vaccination against human papillomavirus as a method of secondary prevention of cervical intraepithelial neoplasia grade 2+ |
|
Klinyshkova T.V.
|
No 9 (2023) |
Postmenopausal osteoporosis |
|
Sulima A.N., Bulyuk V.V., Mitrofanova O.A.
|
No 1 (2014) |
Postmenopausal structural and molecular rearrangements in the polyps and adjacent endometrium: processes of proliferation, neoangiogenesis, aging, and apoptosis |
|
Kogan E.A., Sattarov S.N., Sarkisov S.E., Faizullina N.M.
|
No 3 (2025) |
Postnatal development in children with growth restriction (follow-up study) |
|
Volochaeva M.V., Kan N.E., Tyutyunnik V.L., Leonova A.A., Soldatova E.E., Ryzhova K.O.
|
2401 - 2600 of 4165 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 > >> |